II. Epidemiology
- Accounts for 5% of Emergency Department Chest Pain cases
- Most typical patient is a male aged 20 to 50 years old
- However occurs in both genders and at all ages
III. Pathophysiology: Pericardial Layers
- Parietal Pericardium
- Surrounds heart and limits end diastolic heart volume
- Closely adhered to the Great Vessels and has minimal elasticity
- Pericardial sac
- Between the two pericardial layers
- Typically contains less than 30 cc fluid (15-50 ml)
- Visceral Pericardium (epicardium)
- Delicate lining surrounding heart and Great Vessels
IV. Etiology
VI. Symptoms: Chest Pain
- Pleuritic Chest Pain occurs in 95% of cases
- Timing: Abrupt onset over 5-10 minutes, lasting for hours to days
- Quality: Sharp Pleuritic Chest Pain
- Region: Substernal Chest Pain or left precordial Chest Pain
- Radiation
- Ridge of trapezius (inferior Scapular pole) due to left phrenic nerve irritation (Very specific for Pericarditis)
- Neck, Jaw or Shoulder (similar to Myocardial Infarction radiation)
- Modifying Factors
- Not relieved with Nitroglycerin
- Pleuritic Chest Pain
- Provoked by Swallowing, inspiration, cough
- Positional
- Worse while lying down supine
- Better while sitting, leaning forward
- Precaution
- Acute Myocardial Infarction may present with positional Pleuritic Chest Pain in 16% of cases
- Acute Myocardial Infarction may also present with Pericarditis
VII. Signs
-
Fever (if infectious)
- Fever >101.3 F (38.5 C) may suggest more significant infection (e.g. Tuberculosis, Bacterial Infection)
- Sinus Tachycardia
-
Pericardial Friction Rub (pathognomonic for Pericarditis)
- Uncommonly heard in Pericarditis despite reported occurring in up to 85% of cases (typically transient)
- High-pitched scratchy, squeeking or crunch sound of walking on snow
- Auscultate left sternal border or mid-clavicular line at second to fourth intercostal spaces
- Patient leaning forward and holding breath (distinguishes from pleural rub)
- Unlikely to be heard if Pericardial Effusion present
- Distant heart sounds
- Tamponade signs
- Kussmaul's Sign
- Pulsus paradoxicus
- Jugular Venous Distention
- Associated Myocarditis findings
- See Myocarditis
- Children may present with more subtle findings (e.g. Puffy Eyelids, Sinus Tachycardia)
VIII. Labs: Initial
- Serum Electrolytes
- Serum Troponin I (or other Cardiac Markers)
- Troponin I increased in 15-25% of cases (resolving after 7-14 days)
- Significant Troponin Increases are more suggestive of Myocarditis (or Acute Coronary Syndrome)
- Myocarditis is associated with increased risk of CHF or Arrhythmia
- Mild Troponin elevation may be seen with Pericarditis
- Mildly increased Troponin does not appear to confer overall adverse outcome in Pericarditis
- Acute phase reactants increased
- Complete Blood Count (CBC)
- Erythrocyte Sedimentation Rate (ESR)
- C-Reactive Protein (CRP)
- Increased in 76% of Pericarditis cases
- Resolves within 85% of Pericarditis cases within 2 weeks of treatment onset
IX. Labs: Indicated for Cardiac Tamponade, unknown cause, and duration >7 days
X. Diagnostics: Electrocardiogram (EKG)
- See EKG in Pericarditis
- Precaution
- Exclude Myocardial Infarction first
- Overdiagnosis and misdiagnosis of Pericarditis instead of true STEMI is most significant pitfall
- Obtain serial EKGs
- EKG in Myocardial Infarction evolves over minutes to hours
- EKG in Pericarditis evolves over days
XI. Imaging
-
Chest XRay
- Useful in ruling out Pneumonia or Pneumothorax
- May identify underlying cause (e.g. Tuberculosis, Lung Cancer)
- Rarely diagnostic for Pericarditis
- Pleural Effusion in 50% of cases
- Enlarged cardiac silhouette (water bottle heart)
- Difficult to identify (Compare with old films)
- Present only if Pericardial Effusion >250 ml
- MRI chest or CT chest
- Consider in inconclusive cases or evaluation for purulent Pericarditis (e.g. Staphylococcus aureus)
XII. Imaging: Echocardiogram
- Indications
- Recommended in all Pericarditis cases to evaluate for Pericardial Effusion and estimate ejection fraction
- Preferred Imaging technique indicated for signs of Cardiac Tamponade (Increased JVP or Pulsus Paradoxus)
- Identifies Pericardial Effusion and Cardiac Tamponade
- Findings
- Pericardial Effusions are present in 60% of Pericarditis cases (with most being small effusions, <1 cm wide)
- Echocardiogram is also used to evaluate ejection fraction
- Precautions
- Does not rule out Pericarditis if normal (May be normal in Pericarditis)
- Effusion grading
- Mild effusion: <1 cm wide
- Moderate effusion: 1-2 cm wide
- Large Pericardial Effusion: 2-2.5 cm wide
- Very large Pericardial Effusion: >2.5 cm wide
XIII. Diagnosis: Requires 2 of the following 4 criteria
- Sharp Pleuritic Chest Pain
- Pericardial Friction Rub
- Typical changes associated with EKG in Pericarditis
- New or worsening Pericardial Effusion (more than trivial fluid)
XIV. Differential Diagnosis
- Acute Coronary Syndrome ( Myocardial Ischemia or Myocardial Infarction)
- Gastroesophageal Reflux, Gastritis or Peptic Ulcer Disease
- Pneumonia
- Myocarditis
- Pulmonary Embolism
- Cerebrovascular Accident
- Pneumothorax
- Hyperkalemia
- Pneumopericardium
- Sub-epicardial Hemorrhage
- Ventricular aneurysm
- Aortic Dissection
- Esophageal Rupture
XV. Complications
-
Pericardial Effusion (60% of cases)
- See Echocardiogram above
- Serous effusion: Viral Pericarditis
- Exudative effusion: Neoplastic, Tuberculosis and Bacterial Pericarditis
-
Cardiac Tamponade
- Uncommon in Viral Pericarditis or idiopathic Pericarditis (5-15%)
- Occurs in 60% of exudative cases listed above
- Constrictive Pericarditis
XVI. Evaluation: Severe Pericarditis predictive factors
- Major criteria
- Fever >100.4 F (38 C)
- Subacute onset
- Cardiac Tamponade findings
- Large Pericardial Effusion (>2 cm wide)
- Failed NSAIDs for 7 days
- Minor criteria
- Immunocompromised
- Oral Anticoagulants
- Pericarditis due to acute Trauma
- Troponin Increased (possible myopericarditis)
XVII. Management: Disposition
- Hospitalization Indications
- Anticoagulation therapy
- Fever >100.4 F
- Large Pleural Effusion by Echocardiogram (>2 cm wide)
- Cardiac Tamponade
- Immunocompromised Status
- Traumatic Pericarditis
- Myopericarditis
- Troponin I increased
- Indications for not admitting to hospital
- Age <40 years and
- Conditions on differential diagnosis unlikely and
- No signs of Cardiac Tamponade or large effusion and
- Cardiac enzymes normal and
- Adequate pain control and
- Outpatient monitoring available
XVIII. Management: Medications
- Preacaution: Post-Myocardial Infarction Pericarditis
- Aspirin is first-line therapy for post-Myocardial Infarction Pericarditis (or Pericarditis and known Coronary Artery Disease)
- Aspirin 650-1000 mg every 6-8 hours for 7-10 days and then tapered over 4 weeks
- NSAIDs and Corticosteroids are contraindicated in post-MI Pericarditis
- NSAIDs and Corticosteroids delay healing
- Aspirin is first-line therapy for post-Myocardial Infarction Pericarditis (or Pericarditis and known Coronary Artery Disease)
- Non-Myocardial Infarction related Pericarditis
- Consider adjusting medication protocol and dosing based on acute phase reactant levels
- Consider concurrent GI prophylaxis with Proton Pump Inhibitor (e.g. Omeprazole)
- First line: NSAIDs for 2-4 weeks
- Ibuprofen 600 to 800 mg every 6-8 hours tapered over 4 weeks
- Indomethacin 25-50 mg three times daily tapered over 4 weeks
- Second line: Colchicine and Aspirin
- Aspirin 800 mg q6-8 hours for 7-10 days, then tapered over 3-4 weeks and
- Colchicine 1-2 mg on day 1 and then 0.5 to 1 mg/day for 3 months (divided dosing)
- See Colchicine for adverse effects and lab monitoring
- Colchicine weaned after CRP drops to <3
- Weight > 70 kg (154 lb): 0.5 mg twice daily
- Weight <70 kg (154 lb): 0.5 mg once daily
- Significantly reduces Pericarditis episode duration and recurrence rate
- Refractory cases: Prednisone 10 mg PO qd x1-2 weeks
- Avoid in most cases
- Increased risk of recurrence, especially in Viral Pericarditis (Odds Ratio >4)
- Indications
- Connective Tissue Disease or Autoimmune Condition
- Uremic Pericarditis
- Refractory to NSAIDs and Colchicine
- Protocol
- Prednisone 1 mg/kg/day tapering to 0.25 mg/kg/day and then to NSAIDs over 6-8 weeks
- Taper to NSAIDs and/or Colchicine
- Avoid in most cases
- Antimicrobial agents (rarely indicated)
- Antibiotics for Bacterial Pericarditis
- Antifungals for fungal Pericarditis
- Lyme Disease
- Tuberculosis
- Trypansoma cruzi
XIX. Management: Infectious Pericarditis
- Uncommon (most cases are inflammatory - see above)
- Purulent Bacterial Pericarditis
- Typically empiric antibiotics, then guided by Pericardiocentesis fluid culture and sensitivity
- First-line antibiotics
- Vancomycin 15-20 mg/kg IV every 8-12 hours AND
- Ceftriaxone 2 g IV every 24 hours OR Cefepime 2 g IV every 12 hours
- Alternative regimen
- Vancomycin 15-20 mg/kg IV every 8-12 hours AND
- Ciprofloxacin 750 mg orally twice daily OR 400 mg IV twice daily
- Other infectious causes (consult infectious disease)
- Histoplasmosis (mild cases may be treated as inflammatory Pericarditis, WITHOUT Antifungals)
- Tuberculosis
- References
- (2016) Sanford Guide, accessed 4/8/2016
XX. Management: General
-
General measures
- Head of bed elevated
- Humidified Supplemental Oxygen
- Cardiac monitor
- Pulse Oximetry
- Intravenous Access
- Emergent management for Unstable Patient
- Initial: Pericardiocentesis by experienced clinician
- Refractory: Subxiphoid pericardial drainage and biopsy with histology and culture
-
Pericardiocentesis Indications
- Suspected Bacterial Pericarditis
- Cardiac Tamponade
XXI. Course
- Symptoms typically subsides within 2 weeks
- Recurrence in 15% in a few months after initial episode
XXII. Follow-up
- Obtain formal Echocardiogram within a few days of initial diagnosis if not already done
- Clinic visit 1 week after onset of symptoms
- Repeat EKG at 4 weeks after onset of Pericarditis
XXIII. References
- Claudius in Herbert (2018) EM:Rap 18(8): 6
- Orman and Mattu in Herbert (2015) EM:Rap 15(7): 1-2
- Pacheco and Rawani-Patel (2019) Crit Dec Emerg Med 33(5): 3-11
- Swaminathan and Mattu in Herbert (2020) EM:Rap 20(9): 9-10
- Chiabrando (2020) J Am Coll Cardiol 75(1):76-92 [PubMed]
- Imazio (2007) Int J Cardiol 118(3): 286-94 [PubMed]
- Lange (2004) N Engl J Med 351:2195-202 [PubMed]
- LeWinter (2014) N Engl J Med 371(25): 2410-6 +PMID:25517707 [PubMed]
- Synder (2014) Am Fam Physician 89(7): 553-60 [PubMed]
- Tingle (2007) Am Fam Physician 76: 1509-14 [PubMed]
- Troughton (2004) Lancet 363: 717-27 [PubMed]